Jennifer T. Barrett, PhD
About Jennifer T. Barrett, PhD
Jennifer T. Barrett, PhD, is a Senior Scientist II in Toxicology and Product Development at Entrada Therapeutics, where she has worked since 2021. She has a robust background in non-clinical toxicology, with previous roles at AbbVie, Allergan, and Bristol-Myers Squibb.
Work at Entrada Therapeutics
Jennifer T. Barrett has been employed at Entrada Therapeutics since 2021, serving as a Senior Scientist II in the Toxicology and Product Development department. In this role, she contributes to the advancement of therapeutic products through her expertise in toxicology. Her responsibilities include designing and conducting toxicology studies that adhere to regulatory standards.
Previous Experience in the Pharmaceutical Industry
Before joining Entrada Therapeutics, Barrett held several positions in the pharmaceutical industry. She worked at AbbVie as a Senior Non-Clinical Scientist for nine months in 2020 to 2021. Prior to that, she spent three years at Allergan as a Senior Non-Clinical Development Scientist in Madison, New Jersey. Her earlier roles included positions at Bristol-Myers Squibb, where she served as both a Biological Technician and an Associate Research Scientist.
Education and Expertise
Jennifer Barrett earned her Doctor of Philosophy (Ph.D.) in Toxicology from Rutgers University, where she was part of the Joint Graduate Program from 2009 to 2016. She also holds a Bachelor of Science in Biological Sciences from Ohio University, obtained from 1998 to 2002. Her educational background supports her extensive experience in both GLP and non-GLP non-clinical toxicology studies.
Background in Toxicology Studies
Barrett has a strong background in designing, conducting, and reviewing non-clinical studies. She has worked in various capacities as a Toxicologist and Study Director at organizations such as Envigo and Huntingdon Life Sciences. Her expertise includes monitoring and reporting on non-clinical toxicology studies, which is critical for the development of safe pharmaceutical products.